Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04753216
Title Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Northwestern University

fallopian tube cancer

peritoneum cancer

ovary epithelial cancer


Bevacizumab + MM-398

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.